These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25428456)

  • 1. DI-ICR-FT-MS-based high-throughput deep metabotyping: a case study of the Caenorhabditis elegans-Pseudomonas aeruginosa infection model.
    Witting M; Lucio M; Tziotis D; Wägele B; Suhre K; Voulhoux R; Garvis S; Schmitt-Kopplin P
    Anal Bioanal Chem; 2015 Feb; 407(4):1059-73. PubMed ID: 25428456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caenorhabditis elegans reveals novel Pseudomonas aeruginosa virulence mechanism.
    Utari PD; Quax WJ
    Trends Microbiol; 2013 Jul; 21(7):315-6. PubMed ID: 23684150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa PA14 pathogenesis in Caenorhabditis elegans.
    Kirienko NV; Cezairliyan BO; Ausubel FM; Powell JR
    Methods Mol Biol; 2014; 1149():653-69. PubMed ID: 24818940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Resolution Magic Angle Spinning NMR-Based Metabolomics Revealing Metabolic Changes in Lung of Mice Infected with P. aeruginosa Consistent with the Degree of Disease Severity.
    LeGouëllec A; Moyne O; Meynet E; Toussaint B; Fauvelle F
    J Proteome Res; 2018 Oct; 17(10):3409-3417. PubMed ID: 30129763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swietenia macrophylla extract promotes the ability of Caenorhabditis elegans to survive Pseudomonas aeruginosa infection.
    Dharmalingam K; Tan BK; Mahmud MZ; Sedek SA; Majid MI; Kuah MK; Sulaiman SF; Ooi KL; Khan NA; Muhammad TS; Tan MW; Shu-Chien AC
    J Ethnopharmacol; 2012 Jan; 139(2):657-63. PubMed ID: 22193176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and Lipidomics.
    Ghaste M; Mistrik R; Shulaev V
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The art of serendipity: killing of Caenorhabditis elegans by human pathogens as a model of bacterial and fungal pathogenesis.
    Mylonakis E; Ausubel FM; Tang RJ; Calderwood SB
    Expert Rev Anti Infect Ther; 2003 Jun; 1(1):167-73. PubMed ID: 15482109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A metabolomic study based on accurate mass and isotopic fine structures by dual mode combined-FT-ICR-MS to explore the effects of Rhodiola crenulata extract on Alzheimer disease in rats.
    Zhang X; Jiang X; Wang X; Zhao Y; Jia L; Chen F; Yin R; Han F
    J Pharm Biomed Anal; 2019 Mar; 166():347-356. PubMed ID: 30690248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrahigh resolution mass spectrometry-based metabolic characterization reveals cerebellum as a disturbed region in two animal models.
    Lin S; Kanawati B; Liu L; Witting M; Li M; Huang J; Schmitt-Kopplin P; Cai Z
    Talanta; 2014 Jan; 118():45-53. PubMed ID: 24274269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabotyping of Caenorhabditis elegans and their culture media revealed unique metabolic phenotypes associated to amino acid deficiency and insulin-like signaling.
    Martin FP; Spanier B; Collino S; Montoliu I; Kolmeder C; Giesbertz P; Affolter M; Kussmann M; Daniel H; Kochhar S; Rezzi S
    J Proteome Res; 2011 Mar; 10(3):990-1003. PubMed ID: 21275419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards analytically useful two-dimensional Fourier transform ion cyclotron resonance mass spectrometry.
    van Agthoven MA; Delsuc MA; Bodenhausen G; Rolando C
    Anal Bioanal Chem; 2013 Jan; 405(1):51-61. PubMed ID: 23076397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of dynamically harmonized Fourier transform ion cyclotron resonance cell for high-throughput metabolomics fingerprinting: control of data quality.
    Habchi B; Alves S; Jouan-Rimbaud Bouveresse D; Appenzeller B; Paris A; Rutledge DN; Rathahao-Paris E
    Anal Bioanal Chem; 2018 Jan; 410(2):483-490. PubMed ID: 29167936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A proteomic analysis of Caenorhabditis elegans mitochondria during bacterial infection.
    Mir DA; Balamurugan K
    Mitochondrion; 2019 Sep; 48():37-50. PubMed ID: 30926536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics of transgenic maize combining Fourier transform-ion cyclotron resonance-mass spectrometry, capillary electrophoresis-mass spectrometry and pressurized liquid extraction.
    Leon C; Rodriguez-Meizoso I; Lucio M; Garcia-Cañas V; Ibañez E; Schmitt-Kopplin P; Cifuentes A
    J Chromatogr A; 2009 Oct; 1216(43):7314-23. PubMed ID: 19477454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pseudomonas aeruginosa PA14 type III secretion system is expressed but not essential to virulence in the Caenorhabditis elegans-P. aeruginosa pathogenicity model.
    Wareham DW; Papakonstantinopoulou A; Curtis MA
    FEMS Microbiol Lett; 2005 Jan; 242(2):209-16. PubMed ID: 15621439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Caenorhabditis elegans and Pseudomonas aeruginosa machinery during interactions.
    Vigneshkumar B; Pandian SK; Balamurugan K
    Arch Microbiol; 2012 Apr; 194(4):229-42. PubMed ID: 21909805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caenorhabditis elegans: a model genetic host to study Pseudomonas aeruginosa pathogenesis.
    Tan MW; Ausubel FM
    Curr Opin Microbiol; 2000 Feb; 3(1):29-34. PubMed ID: 10679415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clarification of pathway-specific inhibition by Fourier transform ion cyclotron resonance/mass spectrometry-based metabolic phenotyping studies.
    Oikawa A; Nakamura Y; Ogura T; Kimura A; Suzuki H; Sakurai N; Shinbo Y; Shibata D; Kanaya S; Ohta D
    Plant Physiol; 2006 Oct; 142(2):398-413. PubMed ID: 16905671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficient and novel screening model for assessing the bioactivity of extracts against multidrug-resistant Pseudomonas aeruginosa using Caenorhabditis elegans.
    Zhou YM; Shao L; Li JA; Han LZ; Cai WJ; Zhu CB; Chen DJ
    Biosci Biotechnol Biochem; 2011; 75(9):1746-51. PubMed ID: 21897025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of virulence-related factors in young and aging C. elegans infected with Pseudomonas aeruginosa.
    King CD; Singh D; Holden K; Govan AB; Keith SA; Ghazi A; Robinson RAS
    J Proteomics; 2018 Jun; 181():92-103. PubMed ID: 29656019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.